Clinical Trials Directory

Trials / Completed

CompletedNCT02954224

Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
220 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Delirium is a common complication in elderly patients following surgery. Patients who develop delirium after surgery are at increased risk for serious complications, and even death.This multi-centre randomized controlled trial will enroll elderly patients scheduled for elective hip/knee replacement surgery.The objective of this trial is to identify obstructive sleep apnea using ApneaLink Air and to determine whether auto-titrating CPAP treatment of obstructive sleep apnea will decrease the incidence of post-operative delirium in elderly patients undergoing elective hip and knee replacement surgery.

Detailed description

Delirium is an acute and fluctuating change in cognitive function, characterized by poor attention and disorganized thinking. Recent studies show that patients with obstructive sleep apnea (OSA) - a sleep disorder characterized by repeated episodes of complete or partial blockage of the upper airway - are at greater risk to develop delirium. It is estimated that 43% of men and 27% of women aged 50-70 years old have OSA. Elderly individuals with this condition are often undiagnosed. Unrecognized OSA may be a treatable cause of postoperative delirium. However, timely access to polysomnography is usually not possible prior to surgery. This multi-centre randomized controlled trial will enroll elderly patients scheduled for elective hip/knee replacement surgery. All participants who have given the consent to participate will be assessed risks of OSA and comorbidity by 3 basic questionnaires- STOP-Bang, Epworth Sleepiness Scale and Charlson Comorbidity index, Cognitive level assess by Mini-Cog and baseline delirium assessment by CAM. STOP-Bang questionnaire is the validated questionnaire to screen the patients for OSA. Score of 3 or higher has sensitivity of detecting OSA of 93% and 100% for moderate and severe OSA respectively. If participant has STOP-Bang score 3 or higher will have a home sleep study with the ApneaLink Air and overnight oximetry. Patients identified to have OSA(AHI ≥10/h) will be randomized to 1) Auto-titrating continuous positive airway pressure (CPAP) applied 1-3 nights before surgery (if possible) and during day/night sleep for 72 hrs after surgery or 2) Control group - routine care. All patients will be evaluated for delirium for 72h after surgery.

Conditions

Interventions

TypeNameDescription
OTHERCPAP treatmentPatients who are randomized to auto-titrating CPAP will use an auto CPAP device on postoperative days 1, 2, and 3

Timeline

Start date
2016-03-24
Primary completion
2021-04-30
Completion
2021-12-30
First posted
2016-11-03
Last updated
2022-11-02

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02954224. Inclusion in this directory is not an endorsement.